J Korean Cancer Assoc.
2000 Feb;32(1):53-59.
Clinical Significance of Urokinase - type Plasminogen Activator Receptor ( uPAR ) Expression in Breast Cancer Tissues
- Affiliations
-
- 1Department of Internal Medicine, Eulji Medical Center, Eulji Hospital, Seoul.
- 2Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
- 3Departments of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
- 4Departments of General Surgery, Yonsei University College of Medicine, Seoul, Korea.
- 5Departments of Pathology, Yonsei University College of Medicine, Seoul, Korea.
Abstract
-
PURPOSE: Cancer invasion is induced by several proteolytic enzyme
systems associated with the destruction of basement membrane and
extracellular matrix. Urokinase-type plasminogen activator (uPA) and
plasminogen activator inhibitor-1 (PAI-1) have been reported as prognostic
factors in breast cancer patients and plasminogen activation is regulated
by various factor such as uPAR and growth factor. So we examined the tissue
levels of urokinase-type plasminogen activator receptor (uPAR) in breast
cancer patients.
MATERIALS AND METHODS
Tissue uPAR levels were measured by ELISA assay in 268 breast cancer patients.
RESULTS
The median and mean values of tissue uPAR level in breast cancer were 3.5 ng/mg and 4.8+-3.6 ng/mg cytosol protein, respectively. Tissue uPAR level was the highest in T1 stage, but there was no statistical significance between T stage (p >0.05). In nodal stage, there was also no difference in the value of uPAR according to progression. And the value of uPAR expression was not associated with estrogen and progesteron receptor status, number of involved node and percent of node involvement. In TNM stage, tissue uPAR levels were higher in patients with stage I-II than in patients with stage III-IV (p=0.027). In univariate analysis, nodal factor (p=0.0023) and TNM stage (p=0.0004) were significantly associated with overall survival. But, multivariate analysis showed that TNM stage was the only significant prognostic factor (p=0.0002).
CONCLUSION
These results suggest that uPAR is mainly associated with initial tumor invasion and other factors might be involved in later stages of cancer progression.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinical Relevance of Urokinase-type Plasminogen Activator ( uPA ) , uPA Receptor , Plasminogen Activator Inhibitor-1 Co-expression from Tissue and Serum of Breast Cancer as Targets of Biotherapy
- Urokinase, urokinase receptor, and plasminogen activator inhibitor-1 expression on podocytes in immunoglobulin A glomerulonephritis
- Expression of urokinase: type plasminogen activator, its receptor, and its inhibitor in gastric adenocarcinoma tissues
- Urokinase-type plasminogen activator receptor in IgA nephropathy
- Urokinase Plasminogen Activator Receptor Gene Expression and Clinico-Pathologic Feature in Gastric Cancer Patients
